Medicamen Biotech Ltd. - Research Center
531146 MEDICAMEQ Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 83.17 | 66.62 | 55.39 | 60.05 | 56.89 |
| Operating profit | 13.56 | 11.51 | 11.29 | 12.27 | 9.45 |
| Interest | 1.86 | 1.38 | 1.06 | 0.34 | 0.62 |
| Gross profit | 12.63 | 11.62 | 11.40 | 12.48 | 9.04 |
| EPS (Rs) | 5.87 | 5.69 | 5.35 | 6.85 | 4.36 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 0.93 | 1.49 | 1.17 | 0.56 | 0.22 |
| Stock adjustment | -9.76 | -3.01 | -2.21 | -1.12 | 0.46 |
| Raw material | 53.33 | 36.47 | 28.43 | 27.26 | 35.67 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 10.47 | 9.25 | 7.46 | 7.04 | 4.33 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 15.57 | 12.39 | 10.43 | 14.61 | 6.99 |
| Provisions made | - | - | - | - | - |
| Depreciation | 3.48 | 3.14 | 3.09 | 2.68 | 1.39 |
| Taxation | 1.73 | 1.28 | 1.77 | 1.43 | 2.32 |
| Net profit / loss | 7.43 | 7.20 | 6.53 | 8.37 | 5.33 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 12.65 | 12.65 | 12.22 | 12.22 | 12.22 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 16.31 | 17.28 | 20.38 | 20.43 | 16.60 |
| GPM (%) | 15.02 | 17.06 | 20.15 | 20.59 | 15.84 |
| NPM (%) | 8.83 | 10.57 | 11.55 | 13.82 | 9.33 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis